NCT07268664: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BLMZ Chinese Cohort
- State
- Not started
- Phase
- Phase 3
- People
- 120 planned
- Started
- 1 Dec 2025
- Primary completion
- 31 May 2028
- Arms
- Experimental arm
- Results
- None posted
- 8 Dec 2025: Trial registered